FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063690998> ?p ?o ?g. }

• W2063690998 endingPage "683" @default.
• W2063690998 startingPage "676" @default.
• W2063690998 abstract "Background Despite various attempts at modifying usual treatment modalities, anaplastic thyroid cancer (ATC) is still associated with unfavorable prognosis. Results of preclinical investigations are often of limited transferability to clinical tumor biology. Individualized multimodal treatment regimens, including novel growth-inhibiting drugs, might be a future option. Methods Tumor tissue, freshly prepared from a patient operated for ATC, was xenotransplanted to nude mice. While the patient obtained a hyperfractionated external beam radiation, mice carrying xenotransplanted tumors were randomized (n = 6) and treated by multikinase inhibitors (sorafenib [S]: vascular endothelial growth factor receptor [VEGF-R], platelet derived growth factor receptor, RET; vandetanib [V]: VEGF-R, endothelial growth factor receptor [EGF-R]; and MLN8054 [M]: Aurora kinases [AK]). Antiproliferative, antiangiogenic, and proapoptotic effects were evaluated. Results Treatment of successfully xenotransplanted fresh ATC tumor tissue by multikinase inhibitors and aurora kinase inhibitor reduced the tumor volume up to 61% depending on the drug and time of application (3 wk of treatment: 46% [M], 34% [V], 30% [S]; 5 wk of treatment: 61% [S]). Tumor cell proliferation (BrdU) was reduced between 34% and 58% [S] and [V]. Reduction of tumor vascularity was between 67% [V] and 33% [S] and was accompanied by decreased EGF-R/VEGF-R2 receptor activity [V/V,S]. Tumor cell apoptosis (caspase 3 activity) increased up to 2.4-fold [S]. Conclusions Successful in vivo evaluation of novel drugs in xenotransplanted fresh tumor tissue allows in-time (while patient receives standard treatment) prospective analysis for possible additional clinical application. However, technical specifications have to be taken into account to obtain stable in vivo tumor growth. Based on the individual results, a tailored clinical drug application seems possible." @default.
• W2063690998 created "2016-06-24" @default.
• W2063690998 creator A5003901827 @default.
• W2063690998 creator A5009865973 @default.
• W2063690998 creator A5014645926 @default.
• W2063690998 creator A5050446245 @default.
• W2063690998 creator A5056938980 @default.
• W2063690998 creator A5077316024 @default.
• W2063690998 creator A5077882255 @default.
• W2063690998 creator A5089879417 @default.
• W2063690998 date "2013-12-01" @default.
• W2063690998 modified "2023-09-27" @default.
• W2063690998 title "Pretherapeutic drug evaluation by tumor xenografting in anaplastic thyroid cancer" @default.
• W2063690998 cites W1251167902 @default.
• W2063690998 cites W1979771779 @default.
• W2063690998 cites W1985913922 @default.
• W2063690998 cites W1991774796 @default.
• W2063690998 cites W1997533142 @default.
• W2063690998 cites W2005075630 @default.
• W2063690998 cites W2019766823 @default.
• W2063690998 cites W2034116169 @default.
• W2063690998 cites W2044715980 @default.
• W2063690998 cites W2064261028 @default.
• W2063690998 cites W2068453322 @default.
• W2063690998 cites W2072568732 @default.
• W2063690998 cites W2088380805 @default.
• W2063690998 cites W2093199254 @default.
• W2063690998 cites W2095504978 @default.
• W2063690998 cites W2108461872 @default.
• W2063690998 cites W2108668400 @default.
• W2063690998 cites W2111870457 @default.
• W2063690998 cites W2114833193 @default.
• W2063690998 cites W2126371110 @default.
• W2063690998 cites W2131163278 @default.
• W2063690998 cites W2135494333 @default.
• W2063690998 cites W2139387145 @default.
• W2063690998 cites W2140765540 @default.
• W2063690998 cites W2155008672 @default.
• W2063690998 cites W2158801409 @default.
• W2063690998 cites W2160475600 @default.
• W2063690998 cites W2165902011 @default.
• W2063690998 cites W2172077519 @default.
• W2063690998 doi "https://doi.org/10.1016/j.jss.2013.06.017" @default.
• W2063690998 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23845866" @default.
• W2063690998 hasPublicationYear "2013" @default.
• W2063690998 type Work @default.
• W2063690998 sameAs 2063690998 @default.
• W2063690998 citedByCount "11" @default.
• W2063690998 countsByYear W20636909982015 @default.
• W2063690998 countsByYear W20636909982017 @default.
• W2063690998 countsByYear W20636909982018 @default.
• W2063690998 countsByYear W20636909982019 @default.
• W2063690998 countsByYear W20636909982020 @default.
• W2063690998 countsByYear W20636909982021 @default.
• W2063690998 crossrefType "journal-article" @default.
• W2063690998 hasAuthorship W2063690998A5003901827 @default.
• W2063690998 hasAuthorship W2063690998A5009865973 @default.
• W2063690998 hasAuthorship W2063690998A5014645926 @default.
• W2063690998 hasAuthorship W2063690998A5050446245 @default.
• W2063690998 hasAuthorship W2063690998A5056938980 @default.
• W2063690998 hasAuthorship W2063690998A5077316024 @default.
• W2063690998 hasAuthorship W2063690998A5077882255 @default.
• W2063690998 hasAuthorship W2063690998A5089879417 @default.
• W2063690998 hasConcept C126322002 @default.
• W2063690998 hasConcept C143998085 @default.
• W2063690998 hasConcept C167734588 @default.
• W2063690998 hasConcept C2777025900 @default.
• W2063690998 hasConcept C2778019345 @default.
• W2063690998 hasConcept C2778695046 @default.
• W2063690998 hasConcept C2780333294 @default.
• W2063690998 hasConcept C502942594 @default.
• W2063690998 hasConcept C71924100 @default.
• W2063690998 hasConcept C98274493 @default.
• W2063690998 hasConceptScore W2063690998C126322002 @default.
• W2063690998 hasConceptScore W2063690998C143998085 @default.
• W2063690998 hasConceptScore W2063690998C167734588 @default.
• W2063690998 hasConceptScore W2063690998C2777025900 @default.
• W2063690998 hasConceptScore W2063690998C2778019345 @default.
• W2063690998 hasConceptScore W2063690998C2778695046 @default.
• W2063690998 hasConceptScore W2063690998C2780333294 @default.
• W2063690998 hasConceptScore W2063690998C502942594 @default.
• W2063690998 hasConceptScore W2063690998C71924100 @default.
• W2063690998 hasConceptScore W2063690998C98274493 @default.
• W2063690998 hasIssue "2" @default.
• W2063690998 hasLocation W20636909981 @default.
• W2063690998 hasLocation W20636909982 @default.
• W2063690998 hasOpenAccess W2063690998 @default.
• W2063690998 hasPrimaryLocation W20636909981 @default.
• W2063690998 hasRelatedWork W2016546844 @default.
• W2063690998 hasRelatedWork W2032242790 @default.
• W2063690998 hasRelatedWork W2129810136 @default.
• W2063690998 hasRelatedWork W2554734803 @default.
• W2063690998 hasRelatedWork W2567613149 @default.
• W2063690998 hasRelatedWork W2786166336 @default.
• W2063690998 hasRelatedWork W2887856716 @default.
• W2063690998 hasRelatedWork W3031428341 @default.
• W2063690998 hasRelatedWork W4200474703 @default.
• W2063690998 hasRelatedWork W4293182026 @default.

• next